Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Total Liabilities (2022 - 2026)

Moolec Science (MLECW) posted Total Liabilities of $93.4 million for Q1 2026, up 5.88% sequentially from $88.2 million in Q4 2025.

Moolec Science (MLECW) Total Liabilities (2022 - 2026) Analysis & Trends

Moolec Science has reported Total Liabilities for 5 years, with the latest figure at $93.4 million in Q1 2026.

  • Quarterly Total Liabilities changed N/A year-over-year to $93.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93.4 million (changed N/A YoY) and the FY2025 annual result came in at $289.1 million, down 58.69% from the prior year.
  • Total Liabilities advanced to $93.4 million in Q1 2026 per MLECW's latest filing, from $88.2 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $699.8 million in Q2 2024 and troughed at $4.1 million in Q2 2022.
  • A 5-year average of $100.6 million and a median of $19.3 million in 2024 frame the typical range for Total Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Total Liabilities soared 4918.41% in 2024, then plunged 58.69% in 2025.
  • Over 5 years, Total Liabilities stood at $11.3 million in 2022, then increased by 29.78% to $14.6 million in 2023, then soared by 95.29% to $28.6 million in 2024, then surged by 208.59% to $88.2 million in 2025, then gained by 5.88% to $93.4 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $93.4 million, $88.2 million, and $289.1 million for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 4.20 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 4.00 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4.20 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 3.22 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.35 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 10.03 Bn
10 Moolec Science 8,617.72 -1.19 Mn - 93.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 93.40 Mn
Dec 31, 2025 88.21 Mn
Jun 30, 2025 289.10 Mn
Dec 31, 2024 28.58 Mn
Sep 30, 2024 26.87 Mn
Jun 30, 2024 699.84 Mn
Mar 31, 2024 19.31 Mn
Dec 31, 2023 14.64 Mn
Sep 30, 2023 13.60 Mn
Jun 30, 2023 13.95 Mn
Mar 31, 2023 4.51 Mn
Dec 31, 2022 11.28 Mn
Jun 30, 2022 4.09 Mn